132 related articles for article (PubMed ID: 12431054)
1. Novel, potent ORL-1 receptor agonist peptides containing alpha-Helix-promoting conformational constraints.
Zhang C; Miller W; Valenzano KJ; Kyle DJ
J Med Chem; 2002 Nov; 45(24):5280-6. PubMed ID: 12431054
[TBL] [Abstract][Full Text] [Related]
2. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies on nociceptin analogues: ORL1 receptor binding and biological activity of cyclic disulfide-containing analogues of nociceptin peptides.
Ambo A; Hamazaki N; Yamada Y; Nakata E; Sasaki Y
J Med Chem; 2001 Nov; 44(23):4015-8. PubMed ID: 11689089
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
5. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.
Butour JL; Moisand C; Mazarguil H; Mollereau C; Meunier JC
Eur J Pharmacol; 1997 Feb; 321(1):97-103. PubMed ID: 9083791
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships.
Varani K; Calo G; Rizzi A; Merighi S; Toth G; Guerrini R; Salvadori S; Borea PA; Regoli D
Br J Pharmacol; 1998 Dec; 125(7):1485-90. PubMed ID: 9884077
[TBL] [Abstract][Full Text] [Related]
7. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
[TBL] [Abstract][Full Text] [Related]
8. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
[TBL] [Abstract][Full Text] [Related]
9. [3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor.
Thomsen C; Valsborg JS; Platou J; Martin J; Foged C; Johansen NL; Olsen UB; Madsen K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):538-45. PubMed ID: 11138846
[TBL] [Abstract][Full Text] [Related]
10. The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ.
Tancredi T; Carrà G; Guerrini R; Arduin M; Calò G; Regoli D; Salvadori S; Temussi PA
Chemistry; 2005 Mar; 11(7):2061-70. PubMed ID: 15712334
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A.
Guerrini R; Calo' G; Rizzi A; Bigoni R; Rizzi D; Regoli D; Salvadori S
Peptides; 2000 Jul; 21(7):923-33. PubMed ID: 10998526
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist.
Salvadori S; Guerrini R; Calo G; Regoli D
Farmaco; 1999; 54(11-12):810-25. PubMed ID: 10668183
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.
Guerrini R; Caló G; Bigoni R; Rizzi D; Rizzi A; Zucchini M; Varani K; Hashiba E; Lambert DG; Toth G; Borea PA; Salvadori S; Regoli D
J Med Chem; 2001 Nov; 44(23):3956-64. PubMed ID: 11689082
[TBL] [Abstract][Full Text] [Related]
14. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.
Guerrini R; Calo G; Rizzi A; Bianchi C; Lazarus LH; Salvadori S; Temussi PA; Regoli D
J Med Chem; 1997 Jun; 40(12):1789-93. PubMed ID: 9191955
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of enzymatically resistant nociceptin-related peptides containing a carbamic acid residue.
Ligeti M; Bösze S; Csámpai A; Gündüz O; Al-Khrasani M; Rónai AZ; Medzihradszky-Schweiger H; Benyhe S; Borsodi A; Hudecz F; Magyar A
J Pept Sci; 2006 Jul; 12(7):481-90. PubMed ID: 16550501
[TBL] [Abstract][Full Text] [Related]
16. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
Lapalu S; Moisand C; Mazarguil H; Cambois G; Mollereau C; Meunier JC
FEBS Lett; 1997 Nov; 417(3):333-6. PubMed ID: 9409745
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
[TBL] [Abstract][Full Text] [Related]
19. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
[TBL] [Abstract][Full Text] [Related]
20. A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10.
Bobrova I; Vlaskovska M; Kasakov L; Surovoy A; Egorova N; Johansson L; Karsnas P; Terenius L
Eur J Med Chem; 2003; 38(7-8):687-94. PubMed ID: 12932899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
